European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock • 1 min read

City stockbroker Peel Hunt has estimated that European private equity companies have €270bn worth of unspent capital they need to invest.

"The sheer weight of dry powder, following a period of record fund raising, demands the deployment of capital," the report from the stockbroker said.  Peel Hunt anticipates there will be a focus on takeovers of quoted businesses within the UK as firms accept the new reality of financial conditions. "Potential acquirers of UK plcs have accepted that the cost of debt has structurally increased and that near-zero rates are unlikely to be seen again soon, if ever," the broker said. Private markets to face reality check in 2023 Deal volumes fell last year as rising interest rates...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot